Related Experiment Videos
[Axillobifemoral bypass grafting]
Srpski Arhiv Za Celokupno Lekarstvo
|October 21, 2004
Summary
Axillobifemoral bypass (AxFF) is a viable extra-anatomic procedure for aortoiliac occlusive disease in high-risk patients. Results show comparable early mortality and late graft patency to aortobifemoral bypass (AFF).
Area of Science:
- Vascular Surgery
- Cardiovascular Interventions
- Surgical Outcomes
Context:
- Axillobifemoral bypass (AxFF) serves as an alternative to standard aortoiliac reconstruction.
- It is indicated when anatomic reconstruction is contraindicated due to patient comorbidity or abdominal conditions.
- This study evaluates the efficacy and outcomes of AxFF grafting.
Purpose:
- To present the early and late results of axillobifemoral bypass (AxFF) grafting.
- To delineate the specific indications for performing AxFF bypass.
- To compare AxFF outcomes with standard aortobifemoral bypass (AFF) in patients with aortoiliac occlusive disease.
Summary:
- A total of 37 patients underwent AxFF, primarily for aortoiliac occlusive disease and high-risk comorbidities.
- Early mortality was 13.5%, with causes including sepsis and myocardial infarction.
- Late graft patency was 80.39% at five years, with occlusion attributed to disease progression or anastomotic hyperplasia.
Impact:
- AxFF demonstrates comparable early mortality and late graft patency rates to standard aortobifemoral bypass (AFF).
- The findings support AxFF as a safe and effective option for select high-risk patients.
- This study contributes to the evidence base for managing complex aortoiliac disease.